Amgen Asks 9th Circ. To Undo Shareholder Class Cert.

Law360, Los Angeles (October 14, 2011, 5:42 PM EDT) -- A lawyer for Amgen Inc. told the Ninth Circuit on Friday that a district judge erred by certifying a class of shareholders who allege the biotech company misled investors about two top-selling anemia dugs without considering the materiality of the purported false statements.

Amgen’s attorney Steven Kramer asked the appellate panel to reverse U.S. District Judge Philip S. Gutierrez's certification order, saying the judge should have considered whether the information the company allegedly misstated or concealed concerning its Aranesp and Epogen treatments was even material before...
To view the full article, register now.